Showing results (101-110 of 117) with videos related to

Sort By:
Pageof 12
Journal of Neuroinflammation|August 1, 2021
Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brainXinfeng Guo, Clayton A Wiley, Richard A Steinman, et al.
Chinese Medicine|August 28, 2014
Panax ginseng therapy for chronic obstructive pulmonary disease: a clinical trial protocol and pilot studyLei Wu, Anthony Lin Zhang, Yuan Ming Di, et al.
BMJ Open|May 4, 2019
Chinese herbal medicine for diabetic kidney disease: a systematic review and meta-analysis of randomised placebo-controlled trialsLa Zhang, Lihong Yang, Johannah Shergis, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|March 28, 2013
Ginkgo biloba Extract for Patients with Early Diabetic Nephropathy: A Systematic ReviewLei Zhang, Wei Mao, Xinfeng Guo, et al.
Respiratory Medicine|December 15, 2010
Oral ginseng formulae for stable chronic obstructive pulmonary disease: a systematic reviewXuedong An, Anthony Lin Zhang, Angela Weihong Yang, et al.
Iscience|February 18, 2026
Heterozygous ADAR mutant mice exhibit RNA sensing-dependent neuroinflammation and phenotypes associated with Aicardi-Goutières syndromeXinfeng Guo, Jia-Jun Liu, Chaowei Shang, et al.
Evidence-Based Complementary and Alternative Medicine : Ecam|November 30, 2016
Efficacy of Danlou Tablet in Patients with Non-ST Elevation Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Results from a Multicentre, Placebo-Controlled, Randomized TrialLei Wang, Xujie Zhao, Shuai Mao, et al.
Arthritis Research & Therapy|January 25, 2026
Rheumatoid arthritis and gout: a rare combination or overlooked coexistence?Shaowei Li, Qianying Zhao, Xiao Cai, et al.
Trials|March 9, 2018
Auricular acupressure for insomnia in hemodialysis patients: study protocol for a randomized controlled trialYuchi Wu, Lihong Yang, Lingli Li, et al.
BMC Complementary and Alternative Medicine|September 10, 2015
Rationale and design of the Helping Ease Renal failure with Bupi Yishen compared with the Angiotensin II Antagonist Losartan (HERBAAL) trial: a randomized controlled trial in non-diabetes stage 4 chronic kidney diseaseWei Mao, Lei Zhang, Chuan Zou, et al.
Pageof 12